REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT06693531 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 350 → 368 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06693531 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 350 → 368 participants 3. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical